Genetics of Thoracic Aortic Aneurysm
At the Crossroad of Transforming Growth Factor-β Signaling and Vascular Smooth Muscle Cell Contractility
Aortic aneurysm, including both abdominal aortic aneurysm and thoracic aortic aneurysm, is the cause of death of 1% to 2% of the Western population. This review focuses only on thoracic aortic aneurysms and dissections. During the past decade, the genetic contribution to the pathogenesis of thoracic aortic aneurysms and dissections has revealed perturbed extracellular matrix signaling cascade interactions and deficient intracellular components of the smooth muscle contractile apparatus as the key mechanisms. Based on the study of different Marfan mouse models and the discovery of several novel thoracic aortic aneurysm genes, the involvement of the transforming growth factor-β signaling pathway has opened unexpected new avenues. Overall, these discoveries have 3 important consequences. First, the pathogenesis of thoracic aortic aneurysms and dissections is better understood, although some controversy still exists. Second, the management strategies for the medical and surgical treatment of thoracic aortic aneurysms and dissections are becoming increasingly gene-tailored. Third, the pathogenetic insights have delivered new treatment options that are currently being investigated in large clinical trials.
- aortic aneurysm, thoracic
- Loeys–Dietz syndrome
- Marfan syndrome
- TGF-β signaling
- vascular smooth muscle cell
- Received April 16, 2013.
- Revision received June 20, 2013.
- Accepted June 20, 2013.
- © 2013 American Heart Association, Inc.